了解沃里康纳代谢:一个基于生理学和药物动力学建模的中期框架,整合了体外和临床见解
Ayatallah Saleh1,2,3, Josefine Schulz1, Jan-Frederik Schlender4
1Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.
Clinical pharmacokinetics
|October 30, 2024
概括
这项研究开发了一种基于生理学的药理动力学 (PBPK) 模型,以了解沃里可纳 (VRC) 代谢及其代谢物的影响. 该模型准确预测VRC度,改善治疗策略.
科学领域:
- 药理动力学 药理动力学
- 药物新陈代谢 药物新陈代谢
- 计算机建模 计算建模
背景情况:
- 沃里科纳 (VRC) 由于和代谢,自身抑制和代谢物介导的抑制,表现出非线性药理动力学 (PK).
- 在VRC PK中高的个体间和个体内变异性与CYP2C19遗传多态性和代谢物相互作用有关.
- 伏利康纳N-氧化物 (NO) 和氧伏利康纳 (OHVRC) 抑制CYP酶,有助于VRC PK变异性,并带来治疗挑战.
研究的目的:
- 为VRC,NO和OHVRC开发一个全身生理学基础的药理动力学 (PBPK) 模型.
- 阐明VRC的复杂代谢及其代谢物对母药PK的影响.
- 为了利用体外和体外数据,使用中外方法进行准确的建模.
主要方法:
- 使用PK-Sim®和MoBi®开发了一种结合的父代谢物PBPK模型.
- 假设通过CYP2C19,CYP3A4和CYP2C9形成NO;通过CYP3A4.4形成OHVRC.
- 实施的抑制功能来描述VRC自身抑制和代谢物介导的CYP酶抑制.
主要成果:
- 该PBPK模型准确地预测了不同CYP2C19基因型的健康成年人VRC的血度-时间概况.
- 100%的预测VRC AUC和94%的Cmax值满足了1.25倍的接受标准.
- 所有预测的NO和OHVRC的AUC和Cmax值都符合双重接受标准.
结论:
- 母代谢物PBPK模型量化阐明了VRC代谢及其代谢物对VRC PK的显著影响.
- 综合的建模方法,考虑到自身抑制,代谢物抑制和遗传多态性,增强对VRC PK的理解.
- 该模型可以帮助设计体外实验,推断到儿科群体,并改善治疗个性化,以获得更好的临床结果.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
32
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
32
Pharmacokinetic Models: Overview
600
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
600
Pharmacokinetic Models: Comparison and Selection Criterion
46
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
46
Model Approaches for Pharmacokinetic Data: Physiological Models
33
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
33
Two-Compartment Open Model: IV Infusion
195
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
195
One-Compartment Open Model for IV Bolus Administration: General Considerations
165
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
165


